Numen
ActiveEngineering a future without cancer deaths.
Founders · 2
Luca is an expert in network science and computational game theory. He also has a strong policy background with a focus on healthcare systems. Luca previously worked at Stockdale Street, where he gathered years of experience analyzing, investing in, and helping grow healthcare, consumer, and technology companies. He holds an MSc in Computer Science and an MSc in Global Governance from the University of Oxford where he studied as a Rhodes Scholar. Luca is a Schmidt Futures ISF Fellow.
Clinical cancer researcher with a specialty in bioinformatics, biomarkers, and methods development. Passionate about building better diagnostics and putting a dent in cancer mortality.
Launch
Combining SynBio and AI to make rapid and reliable at-home cancer testing possible
Cleancard develops a rapid at-home cancer testing platform that uses synthetic biology and AI to detect multiple cancer biomarkers from urine in 30 minutes, starting with screens for prostate, bladder, and ovarian cancers. The launch presents the product, its user base (at-home users for early detection), and the core value of faster, more sensitive, multiplexed biomarker testing without complex equipment.
From the original launch (Aug 2023) — may be outdated.
Formerly “Cleancard”
Related startups
We make cancer care at home possible.
We teach your immune system to attack and cure cancer
